Beam Therapeutics stock rises after FDA clearance for BEAM-302 IND
-- Shares of Beam Therapeutics Inc . (NASDAQ:BEAM) climbed 3.7% today following the announcement that the U.S. Food...
-- Shares of Beam Therapeutics Inc . (NASDAQ:BEAM) climbed 3.7% today following the announcement that the U.S. Food...
-- Deutsche Bank has lowered its price target for Tesla (NASDAQ:TSLA), citing a "major reset" of its auto volume...
-- Ukraine’s military issued a statement on Friday, refuting Moscow’s allegations of attacks on Russian energy...
By Lewis Krauskopf and Carolina Mandl NEW YORK (Reuters) - A rocky U.S. stock market will be tested in the coming week by a...
-- Affinity Partners, the asset management firm run by Jared Kushner, has seen its assets under management (AUM)...
-- Analysts at BofA Securities have downgraded their rating on Schneider National (NYSE:SNDR) to “neutral” from...
-- The U.S. Space Force’s Space Systems Command announced on Thursday that it has awarded contracts to Rocket Lab...
-- AppLovin (NASDAQ:APP) Corporation, a mobile tech company, saw its shares surge as much as 9.7% in premarket...
-- The recent pullback in semiconductor stocks, driven by macroeconomic concerns and AI spending uncertainties,...
-- The French Defense Minister, Sebastien Lecornu, has recently had a phone conversation with his U.S. counterpart,...